Intuitive Surgical filings document operating results, governance matters, capital structure, and material events for a Nasdaq-listed medical technology company focused on robotic-assisted surgery. Its Form 8-K reports furnish quarterly and preliminary financial results, procedure information, and exhibits tied to da Vinci and Ion business performance.
Regulatory filings also cover shareholder voting matters, proxy governance, executive compensation, director elections, and officer-role changes. Other material-event disclosures record completed corporate actions, including the acquisition of da Vinci and Ion distribution operations in Europe, alongside formal disclosures about common stock and financial reporting matters.
INTUITIVE SURGICAL INC (ISRG) executive Mark Brosius, EVP & Chief Manufacturing and Supply Chain, reported three small open-market sales of common stock, each for 77 shares, on August 17, 18, and 19, 2026, at per-share prices of $390.67, $394.00, and $394.26, respectively. All transactions were executed under a Rule 10b5-1 trading plan that the company states complies with SEC requirements and expires on February 14, 2027.
INTUITIVE SURGICAL INC director Gary S. Guthart reported an indirect sale of common stock for a trust on August 11, 2026. The trust sold 10,000 shares of common stock at a price of $400.00 per share in an open-market or private transaction. After this sale, the trust held 1,245,679 shares indirectly. Separate indirect holdings of 15,720 shares each are reported in trusts for a daughter and a son. The sale was executed under a Rule 10b5-1 trading plan expiring on June 15, 2027.
Intuitive Surgical Inc. director Amy L. Ladd reported two open-market sales of Intuitive Surgical common stock. On August 10, 2026, she sold 400 shares at $379.00 per share, and on August 11, 2026, she sold 72 shares at $393.10 per share. Both transactions were executed under a Rule 10b5-1 trading plan that expires on May 15, 2027.
Intuitive Surgical Inc. executive Gary Loeb, EVP & Chief Legal and Compliance Officer, reported selling 400 shares of common stock on August 10, 2026 at $379.00 per share. Following this sale, he directly holds 5,320 shares. The sale was executed under a Rule 10b5-1 Trading Plan that expires on January 29, 2027.
Gary Loeb, associated with ISRG, filed a notice to sell common stock under Rule 144. The planned sale covers 400 shares of common stock held through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $151,524.00, listed on NASDAQ.
The shares relate to Restricted Stock Units originally dated 02/26/2025. The filing also notes prior 10b5-1 plan sales of common stock: 400 shares on 06/10/2026 for $169,656.00 and another 400 shares on 05/11/2026 for $178,780.00.
Intuitive Surgical executive Mark Brosius, EVP & Chief Mfg and Supply Cha, reported selling a total of 56 shares of common stock in two open-market or private transactions: 28 shares at 351.0000 per share on July 31, 2026 and 28 shares at 346.8300 per share on July 30, 2026. The sales took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
INTUITIVE SURGICAL INC executive Brosius Mark, EVP & Chief Mfg and Supply Cha, reported selling a total of 84 shares of Common Stock in three open-market transactions. He sold 28 shares on each of July 27, 28, and 29, 2026 at prices between $344.00 and $365.58 per share.
All reported sales were made pursuant to a pre-arranged Trading Plan that complies with SEC Rule 10b5-1, as noted in the footnote, and this plan is stated to expire on February 14, 2027.
Intuitive Surgical, Inc. amended and restated its bylaws on July 23, 2026. The changes allow the company to disregard votes for director nominees submitted by shareholders who do not comply with SEC universal proxy rules, including soliciting holders of 67% of outstanding shares.
The bylaws add expanded disclosure requirements for shareholder director nominations and other business proposals, covering synthetic equity (using SEC-defined terms), investment dates and intent, and proposed bylaw amendment language. Procedural changes limit nominees to the number of seats up for election, require requesting shareholders to be record holders, and require the shareholder to be present in person at meetings.
Additional revisions require any shareholder soliciting proxies to use a non-white proxy card, establish logistics and disclosures for requesting a record date to determine who can call a special meeting, change the voting standard for corporate actions (other than elections) to a majority of votes cast excluding abstentions and broker non-votes, and make conforming technical updates.